SAN DIEGO--(BUSINESS WIRE)--Dec 1, 2018--Bioverativ Inc., a Sanofi company, and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today ...
Saturday, 1 December 2018
At ASH, Extended Half-Life Therapies ELOCTATE® and ALPROLIX® Demonstrate Proven Efficacy and Well-Characterized Safety over Four Years - Associated Press
At ASH, Extended Half-Life Therapies ELOCTATE® and ALPROLIX® Demonstrate Proven Efficacy and Well-Characterized Safety over Four Years Associated Press
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment